163 related articles for article (PubMed ID: 24145283)
21. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.
Jimenez RE; Zalupski MM; Frank JJ; Du W; Ryan JR; Lucas DR
Cancer; 1999 Sep; 86(6):976-81. PubMed ID: 10491523
[TBL] [Abstract][Full Text] [Related]
23. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.
Larkin A; O'Driscoll L; Kennedy S; Purcell R; Moran E; Crown J; Parkinson M; Clynes M
Int J Cancer; 2004 Nov; 112(2):286-94. PubMed ID: 15352042
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance-associated protein 1 predicts relapse in Iranian childhood acute lymphoblastic leukemia.
Mahjoubi F; Akbari S
Asian Pac J Cancer Prev; 2012; 13(5):2285-9. PubMed ID: 22901208
[TBL] [Abstract][Full Text] [Related]
25. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
[TBL] [Abstract][Full Text] [Related]
27. Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial.
Martin-Broto J; Lopez-Alvarez M; Moura DS; Ramos R; Collini P; Romagosa C; Bagué S; Renne SL; Barisella M; Velasco V; Coindre JM; Lopez-Lopez D; Dopazo J; Gambarotti M; Braglia L; Merlo DF; Palmerini E; Stacchiotti S; Quagliuolo VL; Lopez-Pousa A; Grignani G; Blay JY; Brunello A; Gutierrez A; Valverde C; Hindi N; Dei Tos AP; Picci P; Casali PG; Gronchi A
Mol Cancer Ther; 2021 Dec; 20(12):2539-2552. PubMed ID: 34552008
[TBL] [Abstract][Full Text] [Related]
28. Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A; Domont J; Cioffi A; Le Cesne A
Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
[TBL] [Abstract][Full Text] [Related]
29. Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
Citti A; Boldrini R; Inserra A; Alisi A; Pessolano R; Mastronuzzi A; Zin A; De Sio L; Rosolen A; Locatelli F; Fruci D
Int J Oncol; 2012 Jul; 41(1):117-24. PubMed ID: 22504834
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
He SM; Li R; Kanwar JR; Zhou SF
Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116
[TBL] [Abstract][Full Text] [Related]
31. Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319.
Ji Z; Long H; Hu Y; Qiu X; Chen X; Li Z; Fan D; Ma B; Fan Q
J Exp Clin Cancer Res; 2010 Dec; 29(1):158. PubMed ID: 21143841
[TBL] [Abstract][Full Text] [Related]
32. ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas.
Oda Y; Saito T; Tateishi N; Ohishi Y; Tamiya S; Yamamoto H; Yokoyama R; Uchiumi T; Iwamoto Y; Kuwano M; Tsuneyoshi M
Int J Cancer; 2005 May; 114(6):854-62. PubMed ID: 15609299
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
35. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
Gronchi A; Stacchiotti S; Verderio P; Ferrari S; Martin Broto J; Lopez-Pousa A; Llombart-Bosch A; Dei Tos AP; Collini P; Jurado JC; De Paoli A; Donati DM; Poveda A; Quagliuolo V; Comandone A; Grignani G; Morosi C; Messina A; De Sanctis R; Bottelli S; Palassini E; Casali PG; Picci P
Ann Oncol; 2016 Dec; 27(12):2283-2288. PubMed ID: 27733375
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes.
Mercier C; Declèves X; Masseguin C; Fragner P; Tardy M; Roux F; Gabrion J; Scherrmann JM
J Neurochem; 2003 Nov; 87(4):820-30. PubMed ID: 14622113
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract][Full Text] [Related]
38. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
39. The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma.
Soini Y; Järvinen K; Kaarteenaho-Wiik R; Kinnula V
Ann Oncol; 2001 Sep; 12(9):1239-45. PubMed ID: 11697834
[TBL] [Abstract][Full Text] [Related]
40. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
